Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model
Tauopathy comprises a group of disorders caused by abnormal aggregates of tau protein. In these disorders phosphorylated tau protein tends to accumulate inside neuronal cells (soma) instead of the normal axonal distribution of tau. A suggested therapeutic strategy for tauopathy is to induce autophag...
Main Authors: | Salama, Mohamed, Elhussiny, Mahmoud, Magdy, Alshimaa, Omran, Ahmed G., Alsayed, Aziza, Ashry, Ramy, Mohamed, Wael Mohamed Yousef |
---|---|
Format: | Article |
Language: | English English English |
Published: |
Springer Nature
2018
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/58970/ http://irep.iium.edu.my/58970/ http://irep.iium.edu.my/58970/ http://irep.iium.edu.my/58970/30/58970_A%20Survey%20of%20schema%20matching%20research_complete.pdf http://irep.iium.edu.my/58970/13/58970_Dual%20mTORC1_scopus.pdf http://irep.iium.edu.my/58970/24/58970_Dual%20mTORC1-mTORC2%20blocker%20as%20a%20possible%20therapy_WoS.pdf |
Similar Items
-
siRNA blocking of mammalian target of rapamycin (mTOR) attenuates pathology in annonacin-induced tauopathy in mice
by: Salama, Mohamed M., et al.
Published: (2019) -
Pharmacogenetics of beta adrenergic blockers: their clinical significance
by: Elsayed, Tarek Mohamed Ali
Published: (2009) -
Dr.M apa habaq orang muda
by: Mahathir Mohamed
Published: (2016) -
Middle cerebral artery aneurysm - M1/M2 junction aneurysm
by: Awang, Mohamed Saufi
Published: (2013) -
Tau protein as a biomarker for asphyxia: a possible forensic tool?
by: Salama, Mohamed, et al.
Published: (2016)